TuisNTRA • NASDAQ
add
Natera Inc
Vorige sluiting
$242,06
Dagwisseling
$239,00 - $245,59
Jaarwisseling
$125,38 - $245,59
Markkapitalisasie
33,75 mjd USD
Gemiddelde volume
1,56 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 592,18 m | 34,66% |
Bedryfskoste | 481,96 m | 54,93% |
Netto inkomste | -87,54 m | -177,11% |
Netto winsgrens | -14,78 | -105,85% |
Wins per aandeel | -0,64 | -146,15% |
EBITDA | -87,28 m | -180,31% |
Effektiewe belastingkoers | -0,24% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 1,04 mjd | 13,02% |
Totale bates | 1,82 mjd | 14,49% |
Totale aanspreeklikheid | 569,29 m | -20,09% |
Totale ekwiteit | 1,25 mjd | — |
Uitstaande aandele | 138,01 m | — |
Prys om te bespreek | 26,60 | — |
Opbrengs op bates | -13,63% | — |
Opbrengs op kapitaal | -16,86% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -87,54 m | -177,11% |
Kontant van bedrywe | 59,39 m | 14,68% |
Kontant van beleggings | -19,90 m | -146,79% |
Kontant van finansiering | 1,94 m | 12,50% |
Netto kontantverandering | 41,42 m | -56,88% |
Beskikbare kontantvloei | 71,33 m | 77,49% |
Meer oor
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Gestig
01 Jan. 2004
Hoofkwartier
Webwerf
Werknemers
4 429
